192 related articles for article (PubMed ID: 10890580)
1. Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.
Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N
Int J Clin Pharmacol Ther; 2000 Jun; 38(6):309-14. PubMed ID: 10890580
[TBL] [Abstract][Full Text] [Related]
2. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of two nifedipine products in capsule form following single oral administration in healthy volunteers.
Rawashdeh NM; Battah AH; Irshaid YM; al-Qato MK
Eur J Drug Metab Pharmacokinet; 1997; 22(3):259-64. PubMed ID: 9358208
[TBL] [Abstract][Full Text] [Related]
4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
[TBL] [Abstract][Full Text] [Related]
6. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
Wonnemann M; Schug B; Schmücker K; Brendel E; van Zwieten PA; Blume H
Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence study of two brands of enalapril tablets after single oral administration to healthy volunteers.
Niopas I; Daftsios AC; Nikolaidis N
Int J Clin Pharmacol Ther; 2003 May; 41(5):226-30. PubMed ID: 12776814
[TBL] [Abstract][Full Text] [Related]
8. Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults.
Zhang H; Wang S; Wang H; Zhi T; Ren J; Wang Y; Yao Z; Zhang P; Ye N; Zhang R
Clin Pharmacol Drug Dev; 2024 May; 13(5):499-505. PubMed ID: 38478175
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence evaluation of 2 brands of cefuroxime axetil 250 mg tablets in healthy human volunteers.
Pistos C; Michalea S; Kalovidouris M; Kontopoulos G; Georgarakis M
Int J Clin Pharmacol Ther; 2004 Jul; 42(7):367-72. PubMed ID: 15605688
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
[TBL] [Abstract][Full Text] [Related]
11. Determination of nifedipine in human plasma and its use in bioequivalence study.
Guo Y; Dai J; Qian G; Guo N; Ma Z; Guo X
Int J Pharm; 2007 Aug; 341(1-2):91-6. PubMed ID: 17507190
[TBL] [Abstract][Full Text] [Related]
12. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
[TBL] [Abstract][Full Text] [Related]
13. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
Elshafeey AH; Elsherbiny MA; Fathallah MM
Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
[TBL] [Abstract][Full Text] [Related]
14. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioequivalence study of two isotretinoin soft gel capsule formulations in healthy male volunteers.
Georgarakis M; Zougrou F; Tzavara S; Kontopoulos G; Tsiptsios I
Int J Clin Pharmacol Ther; 2003 Jul; 41(7):316-22. PubMed ID: 12875348
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
18. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
Schug BS; Brendel E; Chantraine E; Wolf D; Martin W; Schall R; Blume HH
Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
Bonn M; Eydeler U; Barkworth M; Rovati LC
Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and Tolerability Comparison of Sustained and Immediate Release Oral Formulations of Nifedipine Tablet Formulations: A Single-Dose, Randomized, Open-Label, Two-Period, Two-Way Crossover Study in Healthy, Fasting Egyptian Male Volunteers.
El-Masry SM; El-Khodary NM
Drug Res (Stuttg); 2020 Feb; 70(2-03):91-96. PubMed ID: 31746448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
